US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist
  • 1.120
  • +0.145+14.87%
Close Apr 28 16:00 ET
  • 1.139
  • +0.019+1.71%
Post 19:58 ET
7.31MMarket Cap-0.48P/E (TTM)

About Brainstorm Cell Therapeutics Company

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.

Company Profile

SymbolBCLI
Company NameBrainstorm Cell Therapeutics
Listing DateMay 9, 2003
Founded2000
CEOMr. Chaim Lebovits
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address1325 Avenue of Americas,28th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-201-488-0460
Websitehttp://www.brainstorm-cell.com

Company Executives

  • Name
  • Position
  • Salary
  • Chaim Lebovits
  • President and Chief Executive Officer
  • 750.30K
  • Alla Patlis, C.P.A.,M.B.A.
  • Interim Chief Financial Officer, Principal Accounting Officer and Controller
  • --
  • Uri Yablonka
  • Director, Executive Vice President, Chief Business Officer and Secretary
  • 266.14K
  • Dr. Ibrahim B. Dagher
  • Executive Vice President and Chief Medical Officer
  • 498.58K
  • Dr. Haro Hartounian, PhD
  • Executive Vice President and Chief Operating Officer
  • --
  • Dr. Jacob A. Frenkel, M.A.,PhD
  • Chairman of the Board
  • --
  • Dr. Irit Arbel, PhD
  • Vice Chairman of the Board
  • --
  • Dr. Stacy R. Lindborg, PhD
  • Director
  • 346.38K
  • Nir Naor
  • Independent Director
  • --
  • Dr. Menghisteab Bairu
  • Independent Director
  • 60.00K
  • Dr. Anthony J. Polverino, PhD
  • Independent Director
  • 12.50K

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Oracle
ORCL
140.140
Netflix
NFLX
1110.380
Meta Platforms
META
549.740
4
Apple
AAPL
210.140
5
Tesla
TSLA
285.880
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.